CRVS Q1 2026 Earnings EPS Slightly Misses Estimates Amid Continued Clinical Development Amneal Pharmaceuticals Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency FMNB Q1 2026 Earnings Strong EPS Beat Drives Investor Attention Despite Slight Stock Dip Power Integrations POWI Q1 2026 Earnings EPS Surpasses Estimates as Revenue Details Remain Undisclosed REKR Q1 2026 Earnings EPS Misses Estimates Revenue Data Unavailable Viking Holdings VIK Q1 2026 Earnings NarrowerthanExpected Loss Surprises Market